ResearcherKagawa UniversityActive in the last 2 years
Kyuichi Kadota
Matched on ORCID iD 0000-0002-6835-453X; OpenAlex author ID A5047106223. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 5
2024: 1 paper · 2025: 1 paper
Papers 2
- Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in murine pancreatic cancer. Last author DOI 10.1038/s41598-025-09445-6↗
- Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in pancreatic cancer. Last author DOI 10.1016/j.omton.2024.200812↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Keiko Yamakawa · 2 shared papers, 2024–2025 · strength 0.46
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
- Akira Nishiyama · 2 shared papers, 2024–2025 · strength 0.46
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
- Juanjuan Ye · 2 shared papers, 2024–2025 · strength 0.46
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
- Motohiko Kato · 2 shared papers, 2024–2025 · strength 0.46
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
- Naohisa Yahagi · 2 shared papers, 2024–2025 · strength 0.46
- Paper Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in m… DOI 10.1038/s41598-025-09445-6↗
- Paper Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and augments tumor-infiltrating T cells in… DOI 10.1016/j.omton.2024.200812↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.